| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/14/2005 | US20050079222 Using crosslinked particles of maleic(acid or anhydride)-methyl vinyl ether copolymer |
| 04/14/2005 | US20050079221 Ibuprofen narcotic composition and method for making same |
| 04/14/2005 | US20050079220 Of liquid active materials; reduced voids; encapsulated in impervious material |
| 04/14/2005 | US20050079219 having a continuous coating consisting of a single thermoplastic cellulose ether, particularly ethyl cellulose, for extended release |
| 04/14/2005 | US20050079218 Matrices for the stabilizing and controlled release of problematic substances |
| 04/14/2005 | US20050079217 Tablet with protective coatings; Parkinson's disease; sexual disorders |
| 04/14/2005 | US20050079216 Tablets, pellets in active matrix copolymer; melting, injection molding, extrusion, granulation |
| 04/14/2005 | US20050079215 having a liquid core; core of these capsules comprises a flavoring component and the shell comprises gelatin |
| 04/14/2005 | US20050079214 Capsules; swalling with liquid |
| 04/14/2005 | US20050079213 Solid oral dosage form; cefuroxime axetil in capsule |
| 04/14/2005 | US20050079212 Methods for encapsulating plasmids in lipid bilayers |
| 04/14/2005 | US20050079211 Use of lipid conjugates in the treatment of diseases of the nervous system |
| 04/14/2005 | US20050079210 Mixing, heating with liposome forming material with cosmetics, drugs and solubilizer; cooling |
| 04/14/2005 | US20050079209 Esters of L-carnitine of alkanoyl L-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds |
| 04/14/2005 | US20050079206 Transdermal delivery system for the administration of rotigotine |
| 04/14/2005 | US20050079202 Implantable elastomeric depot compositions and uses thereof |
| 04/14/2005 | US20050079199 Insert for vascular systems; polymer matrix containing pores with therapeutic agents |
| 04/14/2005 | US20050079197 Polymer micelle as monolayer or layer-laminated surface |
| 04/14/2005 | US20050079195 Polymer micelle as monlayer or layer-laminated surface |
| 04/14/2005 | US20050079194 Cosmetic compositions comprising alk(en)ylsuccinic acid derivatives |
| 04/14/2005 | US20050079164 Solubilized CoQ-10 and carnitine |
| 04/14/2005 | US20050079145 Stabilized reverse micelle compositions and uses thereof |
| 04/14/2005 | US20050079138 Methods for making pharmaceutical formulations comprising microparticles with improved dispersibility, suspendability or wettability |
| 04/14/2005 | US20050079137 Heat resistant active material ; mixture with propylene glycol and an excipients |
| 04/14/2005 | US20050079136 Therapy for pain, appetite inttensifiers, multiple sclerosis and asthma; drug delivery |
| 04/14/2005 | US20050079135 Pharmaceutical formulation comprising lanthanum compounds |
| 04/14/2005 | US20050077584 Hermetically sealed microchip reservoir devices |
| 04/14/2005 | US20050077497 Ionization; dispersion in polar solvent |
| 04/14/2005 | US20050076916 Condom |
| 04/14/2005 | DE202005000862U1 Dry composition, useful for providing nutrients required for healthy joints, with some ingredients in rapid-release form and others in slow-release form, in separate components |
| 04/14/2005 | DE10345065A1 Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum Aerosol formulation for inhalation containing an anticholinergic |
| 04/14/2005 | DE10341933A1 Medizinische Hautpflaster mit einem Gehalt an ätherischen Ölen zur Behandlung von Erkältungskrankheiten, sowie Verfahren für deren Herstellung Medical skin patch containing essential oils to treat colds, as well as methods for their preparation |
| 04/14/2005 | CA2582018A1 Buccal, polar and non-polar spray containing zolpidem |
| 04/14/2005 | CA2582008A1 Buccal, polar and non-polar spray containing sumatriptan |
| 04/14/2005 | CA2582007A1 Buccal, polar and non-polar spray containing diazepam |
| 04/14/2005 | CA2554954A1 Buccal, polar and non-polar spray containing ondansetron |
| 04/14/2005 | CA2541974A1 Capsules of multilayered neutral polymer films associated by hydrogen bonding |
| 04/14/2005 | CA2541302A1 Ophthalmic composition for treating tear dysfunction |
| 04/14/2005 | CA2541243A1 Pressure-sensitive adhesive sheet for application to skin |
| 04/14/2005 | CA2540771A1 Nanoparticulate therapeutic biologically active agents |
| 04/14/2005 | CA2540699A1 Polysaccharides for pulmonary delivery of active agents |
| 04/14/2005 | CA2540671A1 Infusion preparation containing (2r)-2-propyloctanoic acid as the active ingredient |
| 04/14/2005 | CA2540670A1 Drug containing (2r)-2-propyloctanoic acid as the active ingredient |
| 04/14/2005 | CA2540537A1 New use, pharmaceutical preparations as well as a process for their production |
| 04/14/2005 | CA2540357A1 Telechelic homopolyamino acids functionalized by hydrophobic groups and uses, particularly therapeutic, thereof |
| 04/14/2005 | CA2539982A1 Pantoprazole multiparticulate formulations |
| 04/14/2005 | CA2539023A1 Triamcinolone acetonide and anecortave acetate formulations for injection |
| 04/14/2005 | CA2538043A1 Osmotically driven active agent delivery device providing an ascending release profile |
| 04/14/2005 | CA2533887A1 Injectable, oral, or topical sustained release pharmaceutical formulations |
| 04/13/2005 | EP1522539A1 Crystalline composition containing escitalopram |
| 04/13/2005 | EP1522317A1 Implantable particles for tissue bulking and the treatment of gastroesophageal reflux disease, urinary incontinence, and skin wrinkles |
| 04/13/2005 | EP1522316A1 Transdermal absorption preparation |
| 04/13/2005 | EP1522312A1 Biologically stable liquid composition of FVIII, of vWF or of FVIII/vWF complex of human origin. |
| 04/13/2005 | EP1522288A2 Ophthalmic treatment |
| 04/13/2005 | EP1522225A1 Bilayer edible sheet |
| 04/13/2005 | EP1522219A1 Antiparasitic formulations |
| 04/13/2005 | EP1521795A2 Heat-sensitive polymers and heat reversible gels derived therefrom |
| 04/13/2005 | EP1521759A2 Metallic object with a nucleic acid coating and derivatives thereof and method for producing said object |
| 04/13/2005 | EP1521672A1 A tablet press machine |
| 04/13/2005 | EP1521602A1 Resorbable structure for treating and healing of tissue defects |
| 04/13/2005 | EP1521599A2 Absorption enhancing agent |
| 04/13/2005 | EP1521597A1 LIQUID FORMULATIONS WITH HIGH CONCENTRATION OF HUMAN GROWTH HORMONE (hgh) COMPRISING 1,2-PROLPYLENE GLYCOL |
| 04/13/2005 | EP1521596A1 Liquid formulations with a high concentration of human growth hormone (hgh) comprising glycine |
| 04/13/2005 | EP1521595A1 Novel drug compositions based on novel anticholinergics and inhibitors of egfr-kinase |
| 04/13/2005 | EP1521593A2 Transdermal botulinum toxin compositions |
| 04/13/2005 | EP1521589A2 Bioactivation of particles |
| 04/13/2005 | EP1521586A2 Use of a chrysanthellum extract |
| 04/13/2005 | EP1521580A1 Novel pharmaceutical compositions comprising novel anticholinergic agents and nk1-receptor antagonists |
| 04/13/2005 | EP1521576A1 Novel pharmaceutical compositions comprising novel anticholinergic agents and pde-iv inhibitors |
| 04/13/2005 | EP1521575A1 Aqueous dispersions of nanometric or micrometric particles for encapsulating chemical compounds |
| 04/13/2005 | EP1521574A1 Solid pharmaceutical composition containing a lipophilic active principle and preparation method thereof |
| 04/13/2005 | EP1521573A1 Non-polymeric lipophilic pharmaceutical implant compositions for intraocular use |
| 04/13/2005 | EP1521572A1 Bioerodible film for ophthalmic drug delivery |
| 04/13/2005 | EP1521571A1 Solid dispersion comprising two different polymer matrixes |
| 04/13/2005 | EP1521570A1 Oral dosage form comprising a liquid active agent formulation and controlling release thereof by an expandable osmotic composition |
| 04/13/2005 | EP1521535A1 Improved bulking agent composition |
| 04/13/2005 | EP1521522A1 Treatment of teats or udders of mammals after milking with barrier-forming foam systems |
| 04/13/2005 | EP1480736A4 Microcapsules having high carotenoid content |
| 04/13/2005 | EP1476193A4 A weight management system for obese animals |
| 04/13/2005 | EP1474171A4 Weight management system for obese animals |
| 04/13/2005 | EP1367996A4 Sustained-release suspension of ceftiofur hydrochloride |
| 04/13/2005 | EP1347787B1 Use of dexpanthenol in contact lens care compositions |
| 04/13/2005 | EP1335706B1 Process fo r the production of microspheres of pancreatic enzymes with high stability |
| 04/13/2005 | EP1274399B1 Liposomes containing an entrapped compound in supersaturated solution |
| 04/13/2005 | EP1246610B1 Instant granules and process for their formulation |
| 04/13/2005 | EP1124440B1 Use of calcareous material for foodstuff and cosmetic material |
| 04/13/2005 | EP1115409A4 Composition for extending post meal satiety |
| 04/13/2005 | EP1115385B1 Use of a composition for manufacturing a medicament for the prevention and treatment of parodontitis |
| 04/13/2005 | EP1113785B1 Clear aqueous solutions of bile acids |
| 04/13/2005 | EP1101490B1 Preparation capable of releasing drug at target site in intestine |
| 04/13/2005 | EP1077709B1 Arsenic sulfide compounds free of arsenic oxide for the treatment of hematological cancers |
| 04/13/2005 | EP1059917B1 Pharmaceutical preparation for use in anti-asthma therapy |
| 04/13/2005 | EP0966257B1 Barrier to plaque formation |
| 04/13/2005 | CN1606620A Slow releasing protein polymer |
| 04/13/2005 | CN1606553A Oxytocin agonistenoxytocin agonisten |
| 04/13/2005 | CN1606472A Adsorbent for phosphoric acid |
| 04/13/2005 | CN1606462A Composition based on etyl ester of linoleic acid and triethyl ester of citric acid for topical use in the treatment of seborrhea and acne |
| 04/13/2005 | CN1606455A Lyophilized preparation containing antibodies to the egf receptor |
| 04/13/2005 | CN1606447A Storage-stable fibrinogen solutions |
| 04/13/2005 | CN1606445A Process for the preparation of pharmaceutical compositions for topical delivery of cyclooxygenase-2-enzyme inhibitors |